Filing Details
- Accession Number:
- 0001209191-12-036236
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-07-02 18:01:30
- Reporting Period:
- 2012-06-28
- Filing Date:
- 2012-07-02
- Accepted Time:
- 2012-07-02 17:01:30
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1009356 | Salix Pharmaceuticals Ltd | SLXP | Pharmaceutical Preparations (2834) | 943267443 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1212670 | J Carolyn Logan | 8510 Colonnade Center Drive Raleigh NC 27615 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2012-06-28 | 228,467 | $4.07 | 763,788 | No | 4 | M | Direct | |
Common Stock | Disposition | 2012-06-28 | 119,300 | $52.07 | 644,488 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Option to Buy Common Stock | Disposition | 2012-06-28 | 228,467 | $0.00 | 228,467 | $4.07 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2012-07-01 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 400,000 | Indirect | by GRAT |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Option to Buy Common Stock | $17.63 | 2015-06-09 | 44,000 | 44,000 | Direct | |
Common Stock | Option to Buy Common Stock | $18.87 | 2014-06-17 | 33,750 | 33,750 | Direct | |
Common Stock | Option to Buy Common Stock | $18.87 | 2014-06-17 | 65,625 | 65,625 | Direct | |
Common Stock | Option to Buy Common Stock | $7.60 | 2013-07-24 | 33,750 | 33,750 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2015-06-09 | 44,000 | 44,000 | Direct |
2014-06-17 | 33,750 | 33,750 | Direct |
2014-06-17 | 65,625 | 65,625 | Direct |
2013-07-24 | 33,750 | 33,750 | Direct |
Footnotes
- The shares covered by this Form 4 were acquired upon exercise of a stock option that was to expire in July 2012. Ms. Logan only sold enough of these shares to pay the exercise price and the related taxes. This sale was pursuant to a Rule 10b5-1 Sales Plan dated December 9, 2011, which is intended to comply with Rule 10b5-1.
- Options are 100% vested.